RELATED STUDY
Key Findings:
Type of Study:
Study Result: Inconclusive
Research Location(s):
Year of Pub:
Cannabinoids Studied:
Chemotype:
Terpenes Studied:
Receptors Studied:
Ligands Studied:
DOSING DETAILS 
Study Dosing Objective: Effective Dose
Established Protocol: Effective dose
Route of Administration:
Dosage Form: β-caryophyllene diluted in olive oil
Dosing Regimen: β-caryophyllene 50 mg/kg i.p. once daily 30 min prior to rotenone (ROT) administration (with or without AM630, a CB2 receptor antagonist)
Treatment Duration: 4 weeks
Clinical Relevance: β-caryophyllene (BCP) has the potential therapeutic efficacy to elicit significant neuroprotection by its anti-inflammatory and antioxidant activities mediated by activation of the CB2 receptors
Citation:
